P3.02b-006 Role of TP53 Mutations in Determining Primary Resistance to First-Line Tyrosine Kinase Inhibitors in EGFR-Mutated NSCLC Patients: Topic: EGFR BiomarkersPaola Ulivi,Matteo Canale,Angelo Delmonte,Elisabetta Petracci,Elisa Chiadini,Claudio Dazzi,Maximilian Papi,Laura Capelli,Claudia Casanova,Nicoletta De Luigi,Marita Mariotti,Alessandro Gamboni,Rita Chiari,Chiara Bennati,Daniele Calistri,Vienna Ludovini,Lucio Crinò,Dino AmadoriJournal of Thoracic Oncology（2017）引用 0|浏览45暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
